These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 1194360)
1. Concurrent development of resistance to 6-azauridine and adenosine in a mouse cell line. Hashmi S; May SR; Krooth RS; Miller OJ J Cell Physiol; 1975 Oct; 86(2 Pt 1):191-200. PubMed ID: 1194360 [TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of purine derivatives on the toxicity of pyrazofurin and 6-azauridine towards cultured mammalian cells. Gupta RS; Moffat MR J Cell Physiol; 1982 Jun; 111(3):291-4. PubMed ID: 6178748 [TBL] [Abstract][Full Text] [Related]
3. Effect of uridine on response of 5-azacytidine-resistant human leukemic cells to inhibitors of de novo pyrimidine synthesis. Grant S; Bhalla K; Gleyzer M Cancer Res; 1984 Dec; 44(12 Pt 1):5505-10. PubMed ID: 6208998 [TBL] [Abstract][Full Text] [Related]
4. Effects of D-glucosamine and 6-azauridine on nucleotide contents, 5-fluorouridine uptake, and cytotoxicity in TA3 mammary tumor cells. Holstege A; Keppler D J Natl Cancer Inst; 1986 Mar; 76(3):485-92. PubMed ID: 2419623 [TBL] [Abstract][Full Text] [Related]
5. Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184. Moy BC; Petzold GL; Badiner GJ; Kelly RC; Aristoff PA; Adams EG; Li LH; Bhuyan BK Cancer Res; 1990 Apr; 50(8):2485-92. PubMed ID: 2317831 [TBL] [Abstract][Full Text] [Related]
6. Effects of selenalysine on thialysine resistant CHO cells. Di Girolamo M; Coccia R; Di Girolamo A; Busiello V; Foppoli C; Cini C Microbiologica; 1986 Oct; 9(4):487-92. PubMed ID: 3095610 [TBL] [Abstract][Full Text] [Related]
7. Effect of inhibitors of the de novo pyrimidine biosynthetic pathway on serum uridine levels in mice. Karle JM; Anderson LW; Dietrick DD; Cysyk RL Cancer Res; 1981 Dec; 41(12 Pt 1):4952-5. PubMed ID: 6171344 [TBL] [Abstract][Full Text] [Related]
8. Acquisition of resistance to 6-azauridine through DNA amplification in neoplastic but not normal osteoblasts. Daniel DL; Tonzetich J; Chernin MI; McMaster JH; Novak JF Anticancer Res; 1994; 14(3A):937-42. PubMed ID: 7521155 [TBL] [Abstract][Full Text] [Related]
9. Stimulation by 6-azauridine of carbamoyl phosphate synthesis for pyrimidine biosynthesis in mouse spleen slices. Tatibana M; Kita K; Asai T Eur J Biochem; 1982 Nov; 128(2-3):625-9. PubMed ID: 6185334 [TBL] [Abstract][Full Text] [Related]
10. 6-Azauridine, an inhibitor of the purine salvage pathway. Partsch G; Eberl R Adv Exp Med Biol; 1977; 76B():170-5. PubMed ID: 855744 [No Abstract] [Full Text] [Related]
11. Identification of 6-azauridine triphosphate in L1210 cells and its possible relevance to cytotoxicity. Wotring LL; Townsend LB Cancer Res; 1989 Jan; 49(2):289-94. PubMed ID: 2463073 [TBL] [Abstract][Full Text] [Related]
12. Development and characterization of a human myelogenous leukemia cell line resistant to 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide. Beran M; Andersson BS Cancer Res; 1987 Apr; 47(7):1897-904. PubMed ID: 3469023 [TBL] [Abstract][Full Text] [Related]
13. Resistance to fluoride of two enzyme-deficient mutants of mouse fibroblasts (L cells). Holland RI; Hongslo JK; Rugstad HE Acta Pharmacol Toxicol (Copenh); 1977 Apr; 40(4):537-40. PubMed ID: 577112 [No Abstract] [Full Text] [Related]
14. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis. Chen SF; Ruben RL; Dexter DL Cancer Res; 1986 Oct; 46(10):5014-9. PubMed ID: 3019518 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes. Gallagher RE; Ferrari AC; Zulich AW; Yen RW; Testa JR Cancer Res; 1984 Jun; 44(6):2642-53. PubMed ID: 6586289 [TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine. Bhalla K; Nayak R; Grant S Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869 [TBL] [Abstract][Full Text] [Related]
17. Isolation of fluoropyrimidine-resistant murine leukemic cell lines by one-step mutation and selection. Mulkins MA; Heidelberger C Cancer Res; 1982 Mar; 42(3):956-64. PubMed ID: 6460554 [TBL] [Abstract][Full Text] [Related]
18. Isolation and analysis of melanoma cell mutants resistant to the antiproliferative action of retinoic acid. Lotan R; Stolarsky T; Lotan D Cancer Res; 1983 Jun; 43(6):2868-75. PubMed ID: 6850598 [TBL] [Abstract][Full Text] [Related]
19. Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells. Wolverton JS; Danks MK; Schmidt CA; Beck WT Cancer Res; 1989 May; 49(9):2422-6. PubMed ID: 2539902 [TBL] [Abstract][Full Text] [Related]
20. Tolerance to O6-methylguanine and 6-thioguanine cytotoxic effects: a cross-resistant phenotype in N-methylnitrosourea-resistant Chinese hamster ovary cells. Aquilina G; Giammarioli AM; Zijno A; Di Muccio A; Dogliotti E; Bignami M Cancer Res; 1990 Jul; 50(14):4248-53. PubMed ID: 2364383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]